| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.701 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 1.946 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.067 |
| Total Expenses - EUR | 1.939 | 1.852 | 787 | 0 | 0 | 0 | 297.563 | 0 | 2.029 | 117.787 |
| Gross Profit/Loss - EUR | 6 | -1.851 | -787 | 0 | 0 | 0 | -297.563 | 0 | -2.029 | -115.720 |
| Net Profit/Loss - EUR | 6 | -1.851 | -787 | 0 | 0 | 0 | -297.563 | 0 | -2.029 | -115.720 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Remedio Farmacii Sa
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 331.189 | 327.811 | 322.264 | 316.350 | 310.224 | 304.342 | 0 | 0 | 0 | 0 |
| Current Assets | 815.652 | 607.585 | 602.708 | 591.647 | 580.189 | 569.190 | 492.632 | 366.444 | 163.906 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 811.054 | 604.853 | 600.154 | 589.140 | 577.731 | 566.778 | 490.277 | 364.082 | 163.581 | 0 |
| Cash | 4.598 | 2.732 | 2.554 | 2.507 | 2.459 | 2.412 | 2.355 | 2.362 | 326 | 0 |
| Shareholders Funds | -629.617 | -625.047 | -615.258 | -603.967 | -592.270 | -581.042 | -865.720 | -868.406 | -867.802 | -978.672 |
| Social Capital | 20.090 | 19.885 | 19.549 | 19.190 | 18.818 | 18.461 | 18.052 | 18.108 | 18.053 | 17.952 |
| Debts | 1.731.648 | 1.560.444 | 1.496.627 | 1.469.161 | 1.440.709 | 1.413.397 | 1.318.087 | 1.194.460 | 991.440 | 938.629 |
| Income in Advance | 44.811 | 44.354 | 43.603 | 42.803 | 41.974 | 41.178 | 40.265 | 40.390 | 40.268 | 40.043 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Remedio Farmacii Sa